IL6R and neoplasm: The mRNA and protein expression of IL-6 and its two receptor subunits gp130 and gp80 was assessed in a panel of nine haematologic tumour cell lines, using flow cytometry, ELISA and RT-PCR, comparing with the triple positive control U266 cells.